Dynamic contrast-enhanced MRI in ovarian cancer: Initial experience at 3 tesla in primary and metastatic disease

Magnetic Resonance in Medicine

Volumn 63, Issue 4, 2010, Pages 1044-1049

  Priest, Andrew N ^a   Gill, Andrew B ^a   Kataoka, Masako ^a   McLean, Mary A ^b   Joubert, Ilse ^a   Graves, Martin J ^a,c   Griffiths, John R ^b   Crawford, Robin A F ^a   Earl, Helena ^a   Brenton, James D ^a,b   Lomas, David J ^c   Sala, Evis ^c  

^a ADDENBROOKE S HOSPITAL   (United Kingdom)

^b CANCER RESEARCH UK CAMBRIDGE RESEARCH INSTITUTE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Dynamic contrast enhanced magnetic resonance imaging; Neo adjuvant chemotherapy; Omental cake; Ovarian cancer; Peritoneal deposit

Indexed keywords

CHEMOTHERAPY; CURVE FITTING; DEPOSITS; MAGNETIC RESONANCE IMAGING; PHARMACOKINETICS;

ADJUVANT CHEMOTHERAPY; DYNAMIC CONTRAST ENHANCED MAGNETIC RESONANCE IMAGING; DYNAMIC CONTRAST ENHANCED MRI; HIGH TEMPORAL RESOLUTION; INTRAVENOUS ADMINISTRATION; OMENTAL CAKE; OVARIAN CANCERS; STATISTICALLY SIGNIFICANT DIFFERENCE;

DISEASES;

GADOBUTROL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; FEMALE; HUMAN; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY CARCINOMA; PERITONEUM; PROSPECTIVE STUDY; QUANTITATIVE DIAGNOSIS; THREE DIMENSIONAL IMAGING; TREATMENT RESPONSE;

EID: 77950597434     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.22291     Document Type: Article

References (35)

1. Tofts PS, Brix G, Buckley DL, Evelhoch JL, Henderson E, Knopp MV, Larsson HB, Lee TY, Mayr NA, Parker GJ, Port RE, Taylor J, Weisskoff RM. Estimating kinetic parameters from dynamic contrastenhanced T (1)-weighted MRI of a diffusable tracer: standardized quantities and symbols. J Magn Reson Imaging 1999;10:223-232.
2. Padhani AR, Leach MO. Antivascular cancer treatments: functional assessments by dynamic contrast-enhanced magnetic resonance imaging. Abdom Imaging 2005;30:324-341.
3. Padhani AR, Dzik-Jurasz A. Perfusion MR imaging of extracranial tumor angiogenesis. Top Magn Reson Imaging 2004;15:41-57.
4. Cuenod CA, Fournier L, Balvay D, Guinebretière JM. Tumor angiogenesis: pathophysiology and implications for contrast-enhanced MRI and CT assessment. Abdom Imaging 2006;31:188-193.
5. Padhani AR, MacVicar AD, Gapinski CJ, Dearnaley DP, Parker GJ, Suckling J, Leach MO, Husband JE. Effects of androgen deprivation on prostatic morphology and vascular permeability evaluated with MR imaging. Radiology 2001;218:365-374.
6. Padhani AR, Husband JE. Dynamic contrast-enhanced MRI studies in oncology with an emphasis on quantification, validation and human studies. Clin Radiol 2001;56:607-620.
7. George ML, Dzik-Jurasz AS, Padhani AR, Brown G, Tait DM, Eccles SA, Swift RI. Non-invasive methods of assessing angiogenesis and their value in predicting response to treatment in colorectal cancer. Br J Surg 2001;88:1628-1636.
8. Zahra MA, Tan LT, Priest AN, Graves MJ, Arends M, Crawford RA, Brenton JD, Lomas DJ, Sala E. Seminiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer. Int J Radiat Oncol Biol Phys 2009;74:766-773.
9. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin 2009;59:225-249.
10. Cannistra SA. Cancer of the ovary. N Engl J Med 1993;329: 1550-1559.
11. Cannistra SA. Cancer of the ovary. N Engl J Med 2004;351: 2519-2529.
12. Agarwal R, Kaye SB. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat Rev Cancer 2003;3:502-516.
13. Sohaib SA, Sahdev A, Van Trappen P, Jacobs IJ, Reznek RH. Characterization of adnexal mass lesions on MR imaging. AJR Am J Roentgenol 2003;180:1297-1304.
14. Van Vierzen PB, Massuger LF, Ruys SH, Barentsz JO. Borderline ovarian malignancy: ultrasound and fast dynamic MR findings. Eur J Radiol 1998;28:136-142.
15. Thomassin-Naggara I, Bazot M, Daraï E, Callard P, Thomassin J, Cuenod CA. Epithelial ovarian tumors: value of dynamic contrastenhanced MR imaging and correlation with tumor angiogenesis. Radiology 2008;248:148-159.
16. Evelhoch JL. Key factors in the acquisition of contrast kinetic data for oncology. J Magn Reson Imaging 1999;10:254-259.
17. Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, Jayson GC, Judson IR, Knopp MV, Maxwell RJ, McIntyre D, Padhani AR, Price P, Rathbone R, Rustin GJ, Tofts PS, Tozer GM, Vennart W, Waterton JC, Williams SR, Workman P. The assessment of antiangiogenic and antivascular therapies in early-stage clinical trials using magnetic resonance imaging: issues and recommendations. Br J Cancer 2005;92:1599-1610.
18. Leach MO, Brindle KM, Evelhoch JL, Griffiths JR, Horsman MR, Jackson A, Jayson G, Judson IR, Knopp MV, Maxwell RJ, McIntyre D, Padhani AR, Price P, Rathbone R, Rustin G, Tofts PS, Tozer GM, Vennart W, Waterton JC, Williams SR, Workman P. Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials. Br J Radiol 2003;76:S87-S91.
19. Weinmann HJ, Laniado M, Mützel W. Pharmacokinetics of GdDTPA /dimeglumine after intravenous injection into healthy volunteers. Physiol Chem Phys Med NMR 1984;16:167-172.
20. Parker GJ, Roberts C, Macdonald A, Buonaccorsi GA, Cheung S, Buckley DL, Jackson A, Watson Y, Davies K, Jayson GC. Experimentally-derived functional form for a population-averaged high-temporal-resolution arterial input function for dynamic contrast-enhanced MRI. Magn Reson Med 2006;56:993-1000.
21. Kuhl CK, Jost P, Morakkabati N, Zivanovic O, Schild H, Gieseke J. Contrast-enhanced MR imaging of the breast at 3.0 and 1.5 T in the same patients: initial experience. Radiology 2006;239:666-676.
22. Kuhl CK, Kooijman H, Gieseke J, Schild HH. Effect of B1 inhomogeneity on breast MR imaging at 3.0 T [letter]. Radiology 2007;244:929-930.
23. Foo TK, Hayes CE, Kang YW. Reduction of RF penetration effects in high field imaging. Magn Reson Med 1992;23:287-301.
24. Schmitt M, Feiweier T, Horger W, Krueger G, Schoen L, Lazar R, Kiefer B. Improved uniformity of R-distribution in clinical whole body imaging at 3T by means of dielectric pads. In: Proceedings of the 12th Annual Meeting of ISMRM, Kyoto, Japan, 2004. p 197.
25. Kershaw LE, Hutchinson CE, Buckley DL. Benign prostatic hyperplasia: evaluation of T1, T2, and microvascular characteristics with T1-weighted dynamic contrast-enhanced MRI. J Magn Reson Imaging 2009;29:641-648.
26. Pintaske J, Martirosian P, Graf H, Erb G, Lodemann KP, Claussen CD, Schick F. Erratum. Invest Radiol 2006;41:859.
27. Referring to: Relaxivity of gadopentetate dimeglumine (Magnevist), gadobutrol (Gadovist), and gadobenate dimeglumine (MultiHance) in human blood plasma at 0.2, 1.5, and 3 tesla. 2006;41:213-221.
28. Tofts PS. Modeling tracer kinetics in dynamic Gd-DTPA MR imaging. J Magn Reson Imaging 1997;7:91-101.
29. Fritz-Hansen T, Rostrup E, Larsson HB, Søndergaard L, Ring P, Henriksen O. Measurement of the arterial concentration of Gd-DTPA using MRI: a step toward quantitative perfusion imaging. Magn Reson Med 1996;36:225-231.
30. Morgan B, Utting JF, Higginson A, Thomas AL, Steward WP, Horsfield MA. A simple, reproducible method for monitoring the treatment of tumours using dynamic contrast-enhanced MR imaging. Br J Cancer 2006;94:1420-1427.
31. Lankester KJ, Taylor JN, Stirling JJ, Boxall J, d'Arcy JA, Collins DJ, Walker-Samuel S, Leach MO, Rustin GJ, Padhani AR. Dynamic MRI for imaging tumor microvasculature: comparison of susceptibility and relaxivity techniques in pelvic tumors. J Magn Reson Imaging 2007;25:796-805.
32. Treier R, Steingoetter A, Fried M, Schwizer W, Boesiger P. Optimized and combined T1 and B1 mapping technique for fast and accurate T1 quantification in contrast-enhanced abdominal MRI. Magn Reson Med 2007;57:568-576.
33. Fram EK, Herfkens RJ, Johnson GA, Glover GH, Karis JP, Shimakawa A, Perkins TG, Pelc NJ. Rapid calculation of T1 using variable flip angle gradient refocused imaging. Magn Reson Imaging 1987;5: 201-208.
34. Ashton E, Raunig D, Ng C, Kelcz F, McShane T, Evelhoch J. Scanrescan variability in perfusion assessment of tumors in MRI using both model and data-derived arterial input functions. J Magn Reson Imaging 2008;28:791-796.
35. Tunariu N, Taylor J, Stirling J, d'Arcy J, Collins DJ, Walker-Samuel S, Padhani AR. Comparing the effects of different pooled arterial input functions on DCE-MRI measurement error analysis across anatomical locations. In: Proceedings of the 16th Annual Meeting of ISMRM, Toronto, Canada, 2008. p 2782.